Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0010453,
umls-concept:C0021760,
umls-concept:C0029925,
umls-concept:C0030685,
umls-concept:C0032659,
umls-concept:C0086418,
umls-concept:C0205225,
umls-concept:C0205359,
umls-concept:C0391871,
umls-concept:C0431085,
umls-concept:C0597032,
umls-concept:C0680255,
umls-concept:C1283071,
umls-concept:C1518071,
umls-concept:C1963578,
umls-concept:C1998793
|
pubmed:issue |
3
|
pubmed:dateCreated |
1995-12-6
|
pubmed:abstractText |
Interleukin-6 (IL-6) is a cytokine that has been implicated as a growth factor in human ovarian carcinoma, yet the in vivo source of IL-6 in patients remains undefined. We measured IL-6 by ELISA in cell-free ascites (CFA) of 19 patients with ovarian carcinoma. IL-6 was detectable in all samples (mean level 3.3 ng/ml). To identify the cellular source of IL-6, we measured this cytokine by ELISA in 24-48 h supernatants of cultured lymphocyte-, macrophage-, and tumor cell-enriched populations purified from three solid ovarian carcinomas by centrifugal elutriation. All cell populations spontaneously released IL-6; however, tumor cells and tumor-associated macrophage released levels of IL-6 that greatly exceeded those released by tumor-associated lymphocytes. Kinetic studies revealed that IL-6 was detectable at 6 h and that levels increased in all cultures examined over a 48 h time course. These data suggest that both tumor and infiltrating host cells may be the source of the high levels of IL-6 found in carcinomatous ascites. Furthermore, although all three cell types examined may contribute to IL-6 production in patients with ovarian carcinoma, tumor cells are perhaps the most clinically significant source.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1079-9907
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
15
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
255-60
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:7584672-Adenocarcinoma,
pubmed-meshheading:7584672-Ascitic Fluid,
pubmed-meshheading:7584672-Cells, Cultured,
pubmed-meshheading:7584672-Cystadenocarcinoma, Papillary,
pubmed-meshheading:7584672-Female,
pubmed-meshheading:7584672-Humans,
pubmed-meshheading:7584672-Interleukin-6,
pubmed-meshheading:7584672-Kinetics,
pubmed-meshheading:7584672-Lymphocytes,
pubmed-meshheading:7584672-Macrophages,
pubmed-meshheading:7584672-Ovarian Neoplasms,
pubmed-meshheading:7584672-Tumor Cells, Cultured
|
pubmed:year |
1995
|
pubmed:articleTitle |
Spontaneous release of interleukin-6 by primary cultures of lymphoid and tumor cell populations purified from human ovarian carcinoma.
|
pubmed:affiliation |
Department of Molecular Biology and Biochemistry, University of California, Irvine 92717, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|